Insider’s View: Deciphering Exelixis Inc (EXEL)’s Financial Health Through Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Exelixis Inc (NASDAQ: EXEL) closed at $29.06 in the last session, down -0.99% from day before closing price of $29.35. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 2.97 million shares were traded. EXEL stock price reached its highest trading level at $29.7499 during the session, while it also had its lowest trading level at $28.89.

Ratios:

We take a closer look at EXEL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 29.87. For the most recent quarter (mrq), Quick Ratio is recorded 4.21 and its Current Ratio is at 4.27. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on October 16, 2024, Reiterated its Outperform rating but revised its target price to $34 from $30 previously.

On September 19, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $30.

Barclays Downgraded its Overweight to Equal Weight on April 11, 2024, while the target price for the stock was maintained at $25.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 23 ’24 when Hessekiel Jeffrey sold 25,000 shares for $26.38 per share. The transaction valued at 659,500 led to the insider holds 605,325 shares of the business.

JEFFREY J HESSEKIEL bought 75,000 shares of EXEL for $1,981,500 on Sep 23 ’24. On Aug 26 ’24, another insider, Hessekiel Jeffrey, who serves as the EVP, General Counsel & Sec of the company, sold 20,000 shares for $25.79 each. As a result, the insider received 515,800 and left with 630,325 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 8289422848 and an Enterprise Value of 7485433344. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.88, and their Forward P/E ratio for the next fiscal year is 19.69. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.12 while its Price-to-Book (P/B) ratio in mrq is 3.91. Its current Enterprise Value per Revenue stands at 3.717 whereas that against EBITDA is 17.433.

Stock Price History:

Over the past 52 weeks, EXEL has reached a high of $29.60, while it has fallen to a 52-week low of $18.64. The 50-Day Moving Average of the stock is 10.04%, while the 200-Day Moving Average is calculated to be 24.50%.

Shares Statistics:

According to the various share statistics, EXEL traded on average about 1.90M shares per day over the past 3-months and 2327430 shares per day over the past 10 days. A total of 302.79M shares are outstanding, with a floating share count of 277.90M. Insiders hold about 2.58% of the company’s shares, while institutions hold 86.06% stake in the company. Shares short for EXEL as of 1727654400 were 10054889 with a Short Ratio of 5.30, compared to 1724976000 on 12028086. Therefore, it implies a Short% of Shares Outstanding of 10054889 and a Short% of Float of 4.7399998.

Most Popular